Dr. Guillermo Abesada-Terk Jr., MD
- Medicare services, 2022
- 51,789
- Part D claims, 2022
- 205
- Publications
- 7
- Clinical trials
- 7
- Industry payments
- $20,040
- Practice address
- 501 Se Osceola St, Stuart, FL 34994-2301
- Practice phone
- Call (772) 223-5952
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Coastal Oncology and Hematology
Physician office · Stuart, Florida
Find Dr. Abesada-Terk's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Guillermo Abesada-Terk Jr. is a medical oncologist in Spring Hill, Florida
Dr. Abesada-Terk practices at Coastal Oncology and Hematology in Stuart, Florida.
Dr. Abesada-Terk's NPI, 1134313273, was assigned on August 31, 2007. Dr. Abesada-Terk graduated from University of Miami, Miller School of Medicine in 1985. Dr. Abesada-Terk holds Florida license ME58862.
- NPI
- 1134313273NPI Registry (opens in a new tab)
- NPI enumeration date
- August 31, 2007
- NPI status
- Active
- Practice phone
- (772) 223-5952
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 67
- Medical school graduation
- 1985
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Guillermo Abesada-Terk Jr. practices in Stuart and Spring Hill
Dr. Abesada-Terk's primary practice is Coastal Oncology and Hematology, at 501 Se Osceola St, Stuart, FL 34994-2301. The practice phone is (772) 223-5952. The NPI Registry lists Dr. Abesada-Terk's practice address as 11063 County Line Rd, Spring Hill, FL 34609.
- Coastal Oncology and HematologyPrimary501 Se Osceola St, Stuart, FL 34994-2301Phone(772) 223-5952
- NPI Registry address11063 County Line Rd, Spring Hill, FL 34609 · Hernando CountyPhone(772) 287-4061
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data
Dr. Guillermo Abesada-Terk Jr. is affiliated with 1 site of care
Dr. Abesada-Terk's primary practice is Coastal Oncology and Hematology in Stuart, Florida.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Guillermo Abesada-Terk Jr.'s practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abesada-Terk practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Coastal Oncology and Hematology | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Guillermo Abesada-Terk Jr. is one of 477 medical oncologists in Florida
Medical oncology is Dr. Abesada-Terk's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Abesada-Terk is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Abesada-Terk's licenses on file in 2 states: Florida and Pennsylvania.
Specialties and state licenses
- Medical oncology, FloridaPrimary
- Pennsylvania license
Medical oncologists near Dr. Abesada-Terk
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Guillermo Abesada-Terk Jr. billed Medicare for 51,789 services in 2022
CMS data shows 51,789 Medicare services from Dr. Abesada-Terk across 42 procedure codes in 2022. Medicare paid $534,546 for them.
Dr. Abesada-Terk's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Other services
- 2021: 41,0102022: 28,62030%
- Drugs given in the office
- 2021: 40,7122022: 17,61457%
- Lab and pathology
- 2021: 4,6202022: 2,76640%
- Tests and treatments
- 2021: 2,1742022: 1,21944%
- Surgery
- 2021: 1,3982022: 88737%
- Office and hospital visits
- 2021: 1,5192022: 68355%
Where Dr. Abesada-Terk's Medicare services took place, 2022
- In an office51,770100%
- In a facility190%
Dr. Abesada-Terk compared with the Florida median for medical oncologists, 2022
- Dr. Abesada-Terk
- Florida median
- Medicare services
- 51,789vs 19,7552.6 times
- Part D claims
- 205vs 59866% below
Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Abesada-Terk's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Abesada-Terk?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Abesada-Terk and other medical oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Guillermo Abesada-Terk Jr.'s patients have a median age of 68
Across all payers, Dmand AI patient panel data puts Dr. Abesada-Terk's median patient age at 68, with 52% women.
Dr. Abesada-Terk's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women52%
- Men46%
Source: Dmand AI Patient Panel Data
Dr. Guillermo Abesada-Terk Jr. wrote 205 Medicare Part D claims in 2022
In 2022, Dr. Abesada-Terk wrote 205 Medicare Part D claims. They cover 10 drugs, with $723,761 in total drug cost. In 2021, CMS named 395 claims across 18 drugs.
Dr. Abesada-Terk's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 3952022: 20548%
Drugs named by CMS: 10 in 2022, 18 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Guillermo Abesada-Terk Jr. has 7 publications on record
Dmand AI links 7 papers to Dr. Abesada-Terk, published from 2010 to 2014. 2014 was the busiest year, with 2. The most frequent topics are Colorectal Neoplasms, Florida and Medical Oncology. Dr. Abesada-Terk has published most often in J Oncol Pract. Dr. Abesada-Terk's most frequent co-authors are Carlos A. Alemany, MD, Thomas Howard Cartwright, MD and Douglas E. Faig, MD.
Dr. Abesada-Terk's papers by year, 2010 to 2014
Topics Dr. Abesada-Terk writes about most
- Colorectal Neoplasms
- Florida
- Medical Oncology
- Quality Indicators, Health Care
- Quality Assurance, Health Care
- Breast Neoplasms
- Guideline Adherence
- Carcinoma, Non-Small-Cell Lung
Dr. Abesada-Terk's most frequent co-authors
- Carlos A. Alemany, MD7 shared papers
- Thomas Howard Cartwright, MD6 shared papers
- Douglas E. Faig, MD6 shared papers
Recent publications by Dr. Abesada-Terk
See who Dr. Abesada-Terk researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Abesada-Terk works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Guillermo Abesada-Terk Jr. has worked on 7 clinical trials
Dmand AI links Dr. Abesada-Terk to 7 clinical trials, 5 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Adenocarcinoma Of Esophagus, Leukemia, Myeloid, Chronic-Phase and Lymphoma, Large B-Cell, Diffuse. Altor BioScience sponsors the most, 2.
Clinical trials with Dr. Abesada-Terk by phase
- NonePhase 1: no trials
- 2Phase 1/2: 2 trials
- NonePhase 2: no trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Abesada-Terk's trials
- Adenocarcinoma Of Esophagus
- Leukemia, Myeloid, Chronic-Phase
- Lymphoma, Large B-Cell, Diffuse
- Melanoma
- Non-Muscle Invasive Bladder Neoplasms
Investigators on the most trials with Dr. Abesada-Terk
- Bruce J. Averbook, MD2 shared trials
- Louis Fehrenbacher, MD2 shared trials
- Charles J. Rosser, MD2 shared trials
Recent clinical trials with Dr. Abesada-Terk
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL (opens in a new tab)
A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer (opens in a new tab)
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Guillermo Abesada-Terk Jr. received $20,040 in industry payments from 2016 to 2024
CMS Open Payments shows 1,177 general payments to Dr. Abesada-Terk from 67 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,072.
General payments to Dr. Abesada-Terk by program year, 2016 to 2024
General payments to Dr. Abesada-Terk by kind, 2016 to 2024
- Food and beverage$18,88294%
- Education$1,1576%
Companies that paid Dr. Abesada-Terk the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Guillermo Abesada-Terk Jr. has 1 award and honors on record
Dmand AI lists 1 award for Dr. Abesada-Terk, most recently CMS Stage 1 EHR in 2012.
Awards and honors for Dr. Abesada-Terk
- 2012
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Guillermo Abesada-Terk Jr. graduated from University of Miami, Miller School of Medicine
Dr. Abesada-Terk graduated from University of Miami, Miller School of Medicine in 1985.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Guillermo Abesada-Terk Jr. accepts plans from 3 insurance carriers
Dr. Abesada-Terk is in network with 3 carriers, including Excellus BlueCross BlueShield, Cigna and Molina. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.
- Excellus BlueCross BlueShield
- Cigna
- Molina
Plan types Dr. Abesada-Terk accepts, by number of carriers
- HMO3
- Medicare3
- PPO2
- EPO1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Guillermo Abesada-Terk Jr.'s profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Guillermo Abesada-Terk Jr.
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Guillermo Abesada-Terk Jr.'s NPI number?
Dr. Guillermo Abesada-Terk Jr.'s NPI number is 1134313273. It was assigned on August 31, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Guillermo Abesada-Terk Jr.?
Dr. Guillermo Abesada-Terk Jr. is a medical oncologist in Spring Hill, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Guillermo Abesada-Terk Jr. practice?
Dr. Abesada-Terk practices at 501 Se Osceola St, Stuart, FL 34994-2301. Dr. Abesada-Terk also practices at 11063 County Line Rd, Spring Hill, FL 34609. Dr. Abesada-Terk's primary practice is Coastal Oncology and Hematology in Stuart, Florida.
What is Dr. Guillermo Abesada-Terk Jr.'s office phone number?
The practice phone on file for Dr. Abesada-Terk is (772) 223-5952.
What is Dr. Guillermo Abesada-Terk Jr.'s medical license number?
Dr. Abesada-Terk holds Florida license ME58862, one of the licenses on file in 2 states.
Which states has Dr. Guillermo Abesada-Terk Jr. been licensed in?
Dmand AI has state licenses on file for Dr. Abesada-Terk in Florida (1990 to 2027) and Pennsylvania (1988 to 1992).
Does Dr. Guillermo Abesada-Terk Jr. accept Medicare?
Yes. CMS data shows Dr. Abesada-Terk billed Medicare for 51,789 services in 2022.
Is Dr. Guillermo Abesada-Terk Jr. board certified?
Yes. Dr. Abesada-Terk is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Guillermo Abesada-Terk Jr. bill to Medicare?
In 2022, Dr. Abesada-Terk's most billed Medicare services were medicare temporary code (Q0138), injected or infused drug (J2182) and medicare temporary code (Q5106).
Where did Dr. Guillermo Abesada-Terk Jr. go to medical school?
Dr. Abesada-Terk graduated from University of Miami, Miller School of Medicine in 1985.
Show 6 more questionsShow fewer questions
What drugs does Dr. Guillermo Abesada-Terk Jr. prescribe most?
In 2022 Medicare Part D data, Dr. Abesada-Terk's most prescribed drugs by claims were Letrozole, Revlimid and Hydroxyurea.
Has Dr. Guillermo Abesada-Terk Jr. received payments from drug or device companies?
CMS Open Payments shows $20,040 in general payments to Dr. Abesada-Terk from 67 companies from 2016 to 2024. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Dr. Guillermo Abesada-Terk Jr. been practicing?
Dr. Abesada-Terk graduated from medical school in 1985, 41 years ago.
Does Dr. Guillermo Abesada-Terk Jr. do research?
Dmand AI links 7 publications to Dr. Abesada-Terk, published from 2010 to 2014. Dr. Abesada-Terk has worked on 7 clinical trials.
Who does Dr. Guillermo Abesada-Terk Jr. publish with?
Dr. Abesada-Terk's most frequent co-authors are Carlos A. Alemany, MD (7 shared papers), Thomas Howard Cartwright, MD (6 shared papers) and Douglas E. Faig, MD (6 shared papers).
What insurance does Dr. Guillermo Abesada-Terk Jr. accept?
Dr. Abesada-Terk is in network with 3 carriers, including Excellus BlueCross BlueShield, Cigna and Molina. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card